HUP9800743A3 - Dithiolan derivatives, their medical use - Google Patents

Dithiolan derivatives, their medical use

Info

Publication number
HUP9800743A3
HUP9800743A3 HU9800743A HUP9800743A HUP9800743A3 HU P9800743 A3 HUP9800743 A3 HU P9800743A3 HU 9800743 A HU9800743 A HU 9800743A HU P9800743 A HUP9800743 A HU P9800743A HU P9800743 A3 HUP9800743 A3 HU P9800743A3
Authority
HU
Hungary
Prior art keywords
medical use
dithiolan derivatives
dithiolan
derivatives
medical
Prior art date
Application number
HU9800743A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of HU9800743D0 publication Critical patent/HU9800743D0/hu
Publication of HUP9800743A2 publication Critical patent/HUP9800743A2/hu
Publication of HUP9800743A3 publication Critical patent/HUP9800743A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HU9800743A 1997-04-02 1998-04-01 Dithiolan derivatives, their medical use HUP9800743A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8374997 1997-04-02
JP883798 1998-01-20

Publications (3)

Publication Number Publication Date
HU9800743D0 HU9800743D0 (en) 1998-05-28
HUP9800743A2 HUP9800743A2 (hu) 2000-05-28
HUP9800743A3 true HUP9800743A3 (en) 2001-10-29

Family

ID=26343433

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800743A HUP9800743A3 (en) 1997-04-02 1998-04-01 Dithiolan derivatives, their medical use

Country Status (24)

Country Link
US (2) US6013663A (hu)
EP (2) EP1070710A3 (hu)
KR (1) KR19980081044A (hu)
CN (1) CN1208035A (hu)
AR (1) AR012315A1 (hu)
AT (1) ATE221525T1 (hu)
AU (1) AU728488B2 (hu)
BR (1) BR9806413A (hu)
CA (1) CA2233682A1 (hu)
CZ (1) CZ96798A3 (hu)
DE (1) DE69806831T2 (hu)
DK (1) DK0869126T3 (hu)
ES (1) ES2179427T3 (hu)
HK (1) HK1015765A1 (hu)
HU (1) HUP9800743A3 (hu)
ID (1) ID19824A (hu)
IL (1) IL123887A0 (hu)
NO (1) NO981469L (hu)
NZ (1) NZ330092A (hu)
PL (1) PL325691A1 (hu)
PT (1) PT869126E (hu)
RU (2) RU2165932C2 (hu)
TR (2) TR199800602A2 (hu)
TW (1) TW508354B (hu)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
WO2000007582A2 (en) * 1998-08-06 2000-02-17 Warner-Lambert Company Use of thiazolidinedione derivatives for the treatment or prevention of cataracts
DE69941800D1 (de) * 1998-10-26 2010-01-21 Univ New York State Res Found Salze von Liponsaürederivaten und deren Verwendung bei der Behandlung von Krankheiten
AU775388B2 (en) 1998-11-25 2004-07-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
FR2787109B1 (fr) * 1998-12-15 2001-01-19 Adir Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
FR2791677B1 (fr) * 1999-04-02 2001-08-17 Sod Conseils Rech Applic Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AR042572A1 (es) * 1999-04-02 2005-06-29 Sod Conseils Rech Applic Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
FR2805537A1 (fr) * 2000-02-24 2001-08-31 Sod Conseils Rech Applic Nouveaux derives de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
IT1312569B1 (it) * 1999-05-21 2002-04-22 Raffaele Ansovini Uso dell'enzima gssg reduttasi per il trattamento terapeutico e laprofilassi di pazienti infettati da hiv.
GB9913226D0 (en) * 1999-06-07 1999-08-04 Novartis Ag Organic compounds
DE19941217A1 (de) * 1999-08-30 2001-03-15 Asta Medica Ag Behandlung der Migräne durch Verabreichung von alpha-Liponsäure oder Derivaten derselben
WO2001025226A1 (en) * 1999-10-05 2001-04-12 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
FR2806409B1 (fr) * 2000-03-16 2002-04-19 Sod Conseils Rech Applic Nouveaux derives heterocycliques de l'acide lipoique, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU4424401A (en) 2000-03-16 2001-09-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
US6387945B2 (en) * 2000-04-11 2002-05-14 The Regents Of The University Of California Lipoic acid analogs
EP1172110A3 (de) * 2000-07-07 2003-09-17 Basf Aktiengesellschaft Verwendung von Liponsäure zur Verbesserung der Bioverfügbarkeit von Mineralsalzen
US8697109B2 (en) 2000-08-16 2014-04-15 Encore Health, Llc Caged mercaptan and seleno-mercaptan compounds and methods of using them
US20050112113A1 (en) * 2000-08-16 2005-05-26 Till Jonathan S. Presbyopia treatment by lens alteration
US8795706B2 (en) * 2000-08-16 2014-08-05 Encore Health, Llc Methods of treating ocular diseases using derivatives of lipoic acid
US7935332B2 (en) * 2000-08-16 2011-05-03 Encore Health, Llc Presbyopia treatment by lens alteration
US8147816B2 (en) * 2000-08-16 2012-04-03 Encore Health, Llc Presbyopia treatment by lens alteration
US7914815B2 (en) * 2000-08-16 2011-03-29 Encore Health, Llc Method for delivery of pharmaceuticals for treating or preventing presbyopia
US6495170B1 (en) * 2000-08-16 2002-12-17 N. V. Nutricia Method of increasing the presence of glutathione in cells
US8647612B2 (en) * 2008-03-05 2014-02-11 Encore Health, Llc Dithiol compounds, derivatives, and treatment of presbyopia
IT1319195B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Processo per la produzione dell'acido r(+)alfa-lipoico.
IT1319196B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Sintesi dell'acido r(+)alfa-lipoico.
DE10201464B4 (de) * 2002-01-16 2005-06-16 Viatris Gmbh & Co. Kg Verfahren zur Herstellung reiner Thioctsäure
AU2003219880A1 (en) * 2002-02-22 2003-09-09 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
WO2003074510A1 (de) * 2002-03-05 2003-09-12 Universitaet Ulm Dithiolan-derivate zur immobilisierung von biomolekülen auf edelmetallen und halbleitern
JP3970811B2 (ja) 2002-09-09 2007-09-05 独立行政法人科学技術振興機構 リンカー化合物及びリガンド、並びにそれらの製造方法
US20040229815A1 (en) * 2003-01-03 2004-11-18 Nagasawa Herbert T. Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug
US7202270B2 (en) * 2003-06-20 2007-04-10 Sami Labs Limited Convenient stable non-hygroscopic crystalline solid forms of racemic and chiral LA-plus salts: process for their manufacture and uses
US7462526B2 (en) * 2003-11-18 2008-12-09 Silicon Genesis Corporation Method for fabricating semiconductor devices using strained silicon bearing material
US20080102119A1 (en) * 2006-11-01 2008-05-01 Medtronic, Inc. Osmotic pump apparatus and associated methods
US7389347B2 (en) * 2004-04-16 2008-06-17 International Business Machines Corporation Active probing for real-time diagnosis
CN101146800A (zh) 2005-01-27 2008-03-19 生物工程大学精神物质实验室 用于治疗阿尔茨海默病的有机化合物,它们的用途和制备方法
WO2007025991A2 (en) * 2005-09-01 2007-03-08 Ares Trading S.A. Treatment of optic neuritis
CN100436444C (zh) * 2006-07-29 2008-11-26 常熟富士莱医药化工有限公司 硫辛酰胺合成工艺
US9239329B2 (en) 2006-12-18 2016-01-19 Japan Science And Technology Agency Method of measuring interaction between biomaterial and sugar chain, method of evaluating biomaterial in sugar chain selectivity, method of screening biomaterial, method of patterning biomaterials, and kits for performing these methods
WO2008106640A1 (en) * 2007-03-01 2008-09-04 Cedars-Sinai Medical Center Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof
KR101056037B1 (ko) * 2007-07-20 2011-08-10 (주)바이오제닉스 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법
WO2009014343A2 (en) * 2007-07-20 2009-01-29 Biogenics, Inc. Ascorbic acid derivatives having alpha-lipoyl groups and process for preparing the same
KR101056039B1 (ko) * 2007-07-20 2011-08-10 (주)바이오제닉스 알파-리포일기 함유 아스코르브산 유도체 및 그의 제조방법
DE102007038849A1 (de) 2007-08-16 2009-02-19 Adscil Gmbh Verwendung von R(+)-alpha-Liponsäure zur Behandlung der kryptogenen Neuropathie
US8102027B2 (en) * 2007-08-21 2012-01-24 Broadcom Corporation IC package sacrificial structures for crack propagation confinement
US9028874B2 (en) * 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
CN101497600B (zh) * 2008-01-29 2012-02-08 首都医科大学 2,4,5-三取代-1,3-二硫戊环、其合成方法、其应用
WO2009111635A2 (en) 2008-03-05 2009-09-11 Encore Health, Llc Dithiol compounds, derivatives, and uses therefor
US9044439B2 (en) * 2008-03-05 2015-06-02 Encore Health, Llc Low dose lipoic and pharmaceutical compositions and methods
EP2291182A1 (en) * 2008-05-13 2011-03-09 Genmedica Therapeutics SL Salicylate conjugates useful for treating metabolic disorders
EP2300451A1 (en) 2008-06-02 2011-03-30 Cedars-Sinai Medical Center Nanometer-sized prodrugs of nsaids
FR2936146B1 (fr) * 2008-09-24 2010-10-08 Oreal Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant.
FR2936153B1 (fr) * 2008-09-24 2010-10-08 Oreal Utilisations de composes dithiolanes pour la photoprotection de la peau ; nouveaux composes dithiolanes ; compositions les contenant.
FR2936706B1 (fr) * 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
FR2937035B1 (fr) * 2008-10-10 2010-12-31 Oreal Composes dithiolanes ; compositions les contenant ; utilisations pour la photoprotection de la peau
WO2010060098A1 (en) 2008-11-24 2010-05-27 Cedars-Sinai Medical Center Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof
FR2939042B1 (fr) 2008-11-28 2010-11-26 Oreal PROCEDE DE DEPIGMENTATION DES MATIERES KERATINIQUES A l'AIDE DE COMPOSES DITHIOLANNES.
CN101787013B (zh) * 2009-01-22 2013-04-24 杭州民生药业有限公司 硫辛酰胺系列衍生物、制备方法及所述衍生物的制药用途
WO2010106082A1 (en) * 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
BRPI1011593A2 (pt) * 2009-03-16 2016-03-22 Genmedica Therapeutics Sl "combinação farmacêutica, composição farmaceuticamente aceitavél, e, método para tratar um distúrbio metabólico, para tratar doença pulmonar obstrutiva crônica, e para tratar ou prevenir um ou mais distúrbios metabólicos."
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
EP2821405B1 (en) 2009-06-15 2016-04-13 Encore Health, LLC Choline esters for treating presbyopia and cataract
FR2952300B1 (fr) * 2009-11-09 2012-05-11 Oreal Nouveaux colorants fluorescents a motif heterocyclique disulfure, composition de teinture les comprenant et procede de coloration des fibres keratiniques humaines a partir de ces colorants
WO2012067947A1 (en) 2010-11-18 2012-05-24 Ischemix Llc Lipoyl compounds and their use for treating ischemic injury
US8466197B2 (en) 2010-12-14 2013-06-18 Genmedica Therapeutics Sl Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders
WO2014078623A2 (en) 2012-11-15 2014-05-22 Brandeis University Tethering cysteine residues using cyclic disulfides
US20160362402A1 (en) * 2014-02-27 2016-12-15 Consorzio Interuniversitario Nazionale Per La Scienza E Tecnologia Dei Materiali Novel compounds having anti-allodynic and antihyperalgesic activity
US20160354340A1 (en) 2014-03-03 2016-12-08 Encore Vision Inc. Lipoic acid choline ester compositions and methods of use
WO2016126662A1 (en) * 2015-02-03 2016-08-11 Kardiatonos, Inc. Compounds for the prevention and treatment of vascular disease
CA2994298A1 (en) 2015-08-18 2017-02-23 Brandeis University Tethering cysteine residues using cyclic disulfides
RU2737377C2 (ru) * 2016-03-14 2020-11-27 Неострата Компани, Инк. N-липоевая аминокислота или пептид, производные и их применение
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN106866620B (zh) * 2017-03-30 2019-09-20 山东齐都药业有限公司 一种硫辛酸氧化杂质的制备方法
EP4282411A1 (en) 2017-04-25 2023-11-29 Ischemix LLC Lipoyl-glu-ala for the treatment of neurodegenerative damage caused by traumatic brain injury
WO2020213693A1 (ja) * 2019-04-17 2020-10-22 参天製薬株式会社 リポ酸プロドラッグ
CN110294738A (zh) * 2019-07-22 2019-10-01 通化师范学院 硫辛酸衍生物及其制备方法和用途
WO2024101918A1 (ko) * 2022-11-11 2024-05-16 주식회사 메디치바이오 리포-하이드록삼산 유도체 및 이의 약학적 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210892B (de) * 1959-10-13 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 5[3-(1, 2-Dithiacylopentyl)]-pentan-saeureamiden
DE1210893B (de) * 1960-06-17 1966-02-17 Fujisawa Pharmaceutical Co Verfahren zur Herstellung von 6, 8-Dithiooctansaeureamiden
FR1294134A (fr) * 1960-12-27 1962-05-26 Takeda Pharmaceutical Ind Procédé de préparation d'alpha-lipoamides
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPH0673005B2 (ja) * 1985-01-24 1994-09-14 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
JPH0670133B2 (ja) * 1985-08-29 1994-09-07 出光興産株式会社 リポアミド膜およびその製造法
JP2553090B2 (ja) 1987-07-21 1996-11-13 帝人株式会社 組織グルタチオンレベル向上剤
FR2653334B1 (fr) * 1989-10-19 1991-12-20 Erphar Ste Civile Preparation cosmetique de bronzage.
DE4000397A1 (de) * 1990-01-09 1991-07-11 Hoechst Ag Lipidselektive antioxidantien sowie deren herstellung und verwendung
IT1252865B (it) * 1991-12-31 1995-06-28 Lifegroup Spa N-acilderivati di aminoalcooli attivi come autocoidi locali ed utilizzabili nella terapia dei processi autoimmuni
IT1256178B (it) 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
FR2707983A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés de l'acide lipoïque et dihydrolipoïque, leur préparation et leur application en thérapeutique humaine.
DE4327462A1 (de) * 1993-08-16 1995-02-23 Carl Heinrich Dr Weischer Neue N-Acetyl-p-Aminophenol-Derivate zur Bekämpfung von Schmerzzuständen
DE4343593C2 (de) * 1993-12-21 1998-05-20 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz
JP2000515111A (ja) * 1995-12-14 2000-11-14 ボリソビチ バラツォフスキィ,マルク サイトカインおよび造血因子の内因性産生増強因子とその利用方法

Also Published As

Publication number Publication date
AU5970298A (en) 1998-10-08
ES2179427T3 (es) 2003-01-16
MX9802679A (es) 1998-12-31
CA2233682A1 (en) 1998-10-02
ATE221525T1 (de) 2002-08-15
IL123887A0 (en) 1998-10-30
HK1015765A1 (en) 1999-10-22
DK0869126T3 (da) 2002-11-18
RU2169731C2 (ru) 2001-06-27
CZ96798A3 (cs) 1998-10-14
CN1208035A (zh) 1999-02-17
DE69806831T2 (de) 2003-03-27
TR200202678A2 (tr) 2004-01-21
EP0869126B1 (en) 2002-07-31
PL325691A1 (en) 1998-10-12
EP0869126A1 (en) 1998-10-07
HUP9800743A2 (hu) 2000-05-28
TR199800602A3 (tr) 1999-10-21
TR199800602A2 (xx) 1999-10-21
EP1070710A3 (en) 2001-03-21
EP1070710A2 (en) 2001-01-24
NO981469L (no) 1998-10-05
AR012315A1 (es) 2000-10-18
AU728488B2 (en) 2001-01-11
TW508354B (en) 2002-11-01
RU2165932C2 (ru) 2001-04-27
BR9806413A (pt) 2003-04-15
NO981469D0 (no) 1998-04-01
KR19980081044A (ko) 1998-11-25
NZ330092A (en) 1999-04-29
DE69806831D1 (de) 2002-09-05
US6313164B1 (en) 2001-11-06
US6013663A (en) 2000-01-11
RU99119545A (ru) 2004-03-27
HU9800743D0 (en) 1998-05-28
ID19824A (id) 1998-08-06
PT869126E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
HUP9800743A3 (en) Dithiolan derivatives, their medical use
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HUP0105414A3 (en) Pyrrolo-isoquinoline, azepino- and diazepino-indole derivatives, their use and pharmaceutical compisitions containing them
HUP9801168A3 (en) Triazinylaminostilbene derivatives
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
GB9802599D0 (en) Medical use
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
ZA982436B (en) Thiazolimine derivatives.
IL137792A0 (en) Alpha-methylstyrene dimer derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
HUP0004565A3 (en) Substituted chroman derivatives, their intermediates and medicines containing the same
GB2321457B (en) 5-Aroylnaphthalene derivatives
HUP0000491A3 (en) Herbicidal substituted 4-benzoyl-pyrazole derivatives, preparation and use thereof
GB9701628D0 (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
ZA983116B (en) Arylsecocholadiene derivatives
HU9800889D0 (en) New naphtylpiperazine derivatives
IL133242A0 (en) 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
HUP0003622A3 (en) Fungicidal pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives, their preparation, intermediates and use
GB9706753D0 (en) Aralkoxy-morphinan derivatives